Genenta Science S.p.A. (GNTA)
USD 5.15
(-2.83%)
USD 5.15
(-2.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -10.97 Million | -7.41 Million | -6.95 Million | -6.04 Million | -2.49 Million |
| Net Income | -11.4 Million | -8.47 Million | -5.52 Million | -5.59 Million | -4.59 Million |
| Depreciation & Amortization | 41.58 Thousand | 6140.00 | 4889.00 | 1900.00 | - |
| Deferred income taxes | -823.04 Thousand | - | - | - | - |
| Stock-based compensation | 739.88 Thousand | 722.73 Thousand | 497.1 Thousand | 460.19 Thousand | 749.51 Thousand |
| Change in working capital | -409.03 Thousand | 240.29 Thousand | -1.94 Million | -920.71 Thousand | 1.35 Million |
| Other non-cash items | 882.02 Thousand | 90.35 Thousand | 13.23 Thousand | 6056.00 | 4867.00 |
| Investing Cash Flow | -14.58 Million | -27.07 Thousand | -9009.00 | -20.87 Thousand | - |
| Investments in PPE | -13.5 Thousand | -27.07 Thousand | -9009.00 | -20.87 Thousand | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -14.57 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -1.00 | -27.07 Million | -9 Million | - | - |
| Financing Cash Flow | 520.12 | - | 28.74 Million | 1.38 Million | 14.76 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 520.12 | - | 28.74 Million | 1.5 Million | 15.08 Million |
| Other Financing Activities | 0.53 | - | 543.00 | -111.12 Thousand | -318.5 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -728.17 Thousand | 1 Million | -365.14 Thousand | -17.42 Thousand | -27.58 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | 319.14 Thousand | -763.87 Thousand | -1.57 Million | -903.29 Thousand | 1.38 Million |
| Cash at beginning of period | 29.71 Million | 37.24 Million | 15.46 Million | 20.14 Million | 7.86 Million |
| Cash at end of period | 3.69 Million | 29.79 Million | 37.24 Million | 15.46 Million | 20.14 Million |
| Capital Expenditure | -13.5 Thousand | -27.07 Thousand | -9009.00 | -20.87 Thousand | - |
| Effect of forex changes on cash | -6278.00 | - | - | - | - |
| Net cash flow / Change in cash | -26.01 Million | -7.44 Million | 21.77 Million | -4.67 Million | 12.27 Million |
| Free Cash Flow | -10.98 Million | -7.44 Million | -6.96 Million | -6.06 Million | -2.49 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2443.12 | -11.4 Million | -2443.12 | -6.69 Million | -3379.61 | -8.47 Million |
| Depreciation & Amortization | 10.66 | 41.58 Thousand | 10.66 | 20.94 Thousand | 10.57 | 6140.00 |
| Deferred income taxes | -41.92 Thousand | -823.04 Thousand | - | -42.1 Thousand | - | - |
| Stock-based compensation | 161.73 | 739.88 Thousand | 161.73 | 208.22 | 208.22 | 722.73 Thousand |
| Change in working capital | 447.10 | -409.03 Thousand | 447.10 | -1.28 Million | -291.81 | 240.29 Thousand |
| Other non-cash items | 11.19 | 882.02 Thousand | 11.19 | 493.76 Thousand | -337.43 | 90.35 Thousand |
| Investing Cash Flow | -2445.60 | -14.58 Million | -2445.60 | -9.9 Million | -5000.73 | -27.07 Thousand |
| Investments in PPE | -0.68 | -13.5 Thousand | -0.68 | -12.32 Thousand | -6.22 | -27.07 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -4.8 Million | -14.57 Million | - | -9.89 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2444.92 | -1.00 | -2444.92 | -4994.51 | -4994.51 | -27.07 Million |
| Financing Cash Flow | 0.27 | 520.12 | 0.27 | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 520.37 | 520.12 | - | - | - | - |
| Other Financing Activities | 0.27 | 0.53 | 0.27 | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | -728.17 Thousand | - | - | - | 1 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 447.10 | 319.14 Thousand | 447.10 | -1.28 Million | -291.81 | -763.87 Thousand |
| Cash at beginning of period | 12.21 Million | 29.71 Million | - | 29.63 Million | - | 37.24 Million |
| Cash at end of period | 3.69 Million | 3.69 Million | -4260.92 | 12.21 Million | -8790.80 | 29.79 Million |
| Capital Expenditure | -0.68 | -13.5 Thousand | -0.68 | -12.32 Thousand | -6.22 | -27.07 Thousand |
| Effect of forex changes on cash | -3.14 | -6278.00 | -3.14 | - | - | - |
| Net cash flow / Change in cash | -8.52 Million | -26.01 Million | -4260.92 | -17.41 Million | -8790.80 | -7.44 Million |
| Free Cash Flow | -1813.12 | -10.98 Million | -1813.12 | -7.52 Million | -3796.28 | -7.44 Million |
TTZ
600601
THANI
TIG
002728
ADEN